These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33126239)

  • 1. The influence of glatiramer acetate on Th17-immune response in multiple sclerosis.
    Melnikov M; Sharanova S; Sviridova A; Rogovskii V; Murugina N; Nikolaeva A; Dagil Y; Murugin V; Ospelnikova T; Boyko A; Pashenkov M
    PLoS One; 2020; 15(10):e0240305. PubMed ID: 33126239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis.
    Hussien Y; Sanna A; Söderström M; Link H; Huang YM
    J Neuroimmunol; 2001 Dec; 121(1-2):102-10. PubMed ID: 11730946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of interferon and glatiramer acetate on cytokine patterns in multiple sclerosis patients.
    Ganji A; Monfared ME; Shapoori S; Nourbakhsh P; Ghazavi A; Ghasami K; Mosayebi G
    Cytokine; 2020 Feb; 126():154911. PubMed ID: 31731047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Evolving Mechanisms of Action of Glatiramer Acetate.
    Prod'homme T; Zamvil SS
    Cold Spring Harb Perspect Med; 2019 Feb; 9(2):. PubMed ID: 29440323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of glatiramer acetate (Copaxone) on CD4+CD25high T regulatory cells and their IL-10 production in multiple sclerosis.
    Putheti P; Soderstrom M; Link H; Huang YM
    J Neuroimmunol; 2003 Nov; 144(1-2):125-31. PubMed ID: 14597106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis.
    Sellner J; Koczi W; Harrer A; Oppermann K; Obregon-Castrillo E; Pilz G; Wipfler P; Afazel S; Haschke-Becher E; Trinka E; Kraus J
    Clin Exp Immunol; 2013 Sep; 173(3):381-9. PubMed ID: 23611040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis: expression of CD1a and production of IL-12p70 and IFN-gamma by blood mononuclear cells in patients on combination therapy with IFN-beta and glatiramer acetate compared to monotherapy with IFN-beta.
    Hussien Y; Sanna A; Söderström M; Link H; Huang YM
    Mult Scler; 2004 Feb; 10(1):16-25. PubMed ID: 14760948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glatiramer Acetate: from Bench to Bed and Back.
    Arnon R; Aharoni R
    Isr Med Assoc J; 2019 Mar; 21(3):151-157. PubMed ID: 30905097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab.
    Oreja-Guevara C; Ramos-Cejudo J; Aroeira LS; Chamorro B; Diez-Tejedor E
    BMC Neurol; 2012 Sep; 12():95. PubMed ID: 22989378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of fluoxetine on neuroimmune interaction in multiple sclerosis].
    Melnikov MV; Lopatina AV; Sviridova AA; Pashenkov MV; Boyko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(7. Vyp. 2):65-71. PubMed ID: 37560836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term therapy with glatiramer acetate in multiple sclerosis: effect on T-cells.
    Ragheb S; Abramczyk S; Lisak D; Lisak R
    Mult Scler; 2001 Feb; 7(1):43-7. PubMed ID: 11321193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine suppresses Th17 and dendritic cell responses.
    Yang Y; Qi J; Wang Q; Du L; Zhou Y; Yu H; Kijlstra A; Yang P
    Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2516-22. PubMed ID: 23482469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis.
    Karandikar NJ; Crawford MP; Yan X; Ratts RB; Brenchley JM; Ambrozak DR; Lovett-Racke AE; Frohman EM; Stastny P; Douek DC; Koup RA; Racke MK
    J Clin Invest; 2002 Mar; 109(5):641-9. PubMed ID: 11877472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A one year follow-up study of natural killer and dendritic cells activities in multiple sclerosis patients receiving glatiramer acetate (GA).
    Høglund RA; Holmøy T; Harbo HF; Maghazachi AA
    PLoS One; 2013; 8(4):e62237. PubMed ID: 23614042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of multiple sclerosis with glatiramer acetate: a new look].
    Boyko AN; Smirnova NF; Shchukin IA; Lasch NY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(7. Vyp. 2):56-61. PubMed ID: 34387447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glatiramer acetate (copolymer-1, copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells.
    Vieira PL; Heystek HC; Wormmeester J; Wierenga EA; Kapsenberg ML
    J Immunol; 2003 May; 170(9):4483-8. PubMed ID: 12707324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis of CD4+ T cells by immunomodulatory therapy of multiple sclerosis with glatiramer acetate.
    Rieks M; Hoffmann V; Aktas O; Juschka M; Spitzer I; Brune N; Schimrigk S; Przuntek H; Pöhlau D
    Eur Neurol; 2003; 50(4):200-6. PubMed ID: 14634263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of viral and self-antigens by T
    Paroni M; Maltese V; De Simone M; Ranzani V; Larghi P; Fenoglio C; Pietroboni AM; De Riz MA; Crosti MC; Maglie S; Moro M; Caprioli F; Rossi R; Rossetti G; Galimberti D; Pagani M; Scarpini E; Abrignani S; Geginat J
    J Allergy Clin Immunol; 2017 Sep; 140(3):797-808. PubMed ID: 28237728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis in CD4(+) T-cells is linked with optimal treatment response in patients with relapsing-remitting multiple sclerosis treated with Glatiramer acetate.
    Boziki M; Lagoudaki R; Melo P; Kanidou F; Bakirtzis C; Nikolaidis I; Grigoriadou E; Afrantou T; Tatsi T; Matsi S; Grigoriadis N
    J Neurol Sci; 2019 Jun; 401():43-50. PubMed ID: 31009931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological activity of glatiramer acetate on Treg and anti-inflammatory monocytes persists for more than 10years in responder multiple sclerosis patients.
    Spadaro M; Montarolo F; Perga S; Martire S; Brescia F; Malucchi S; Bertolotto A
    Clin Immunol; 2017 Aug; 181():83-88. PubMed ID: 28642148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.